Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastomacells
Mg. Cattaneo et al., Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastomacells, FEBS LETTER, 481(3), 2000, pp. 271-276
In previous studies me have showed that somatostatin (SST) inhibits cell di
vision, mitogen-activated protein (MAP) kinase and Ras activity in the huma
n neuroblastoma cell line SY5Y, In the present study, we have assessed the
role of a series of SST analogs, three of which were selective for SSTR1, S
STR2 or SSTR5, in these cellular events. All the analogs inhibited forskoli
n-induced cAMP accumulation. Selective stimulation of SSTR1 or SSTR2 but no
t of SSTR5 inhibited platelet-derived growth factor (PDGF)-induced [H-3]thy
midine incorporation. The three analogs inhibited PDGF-stimulated MAP kinas
e activity, at least at an early time, In contrast, none of the analogs use
d individually was able to inhibit PDGF-stimulated Ras activity. A combined
stimulation of SSTR2 and SSTR5 was necessary to obtain a significant inhib
itory effect, suggesting the possibility of receptor heterodimerization. Th
ese results indicate that SST inhibition of Ras and MAP kinase activities t
akes place via different pathways and that SST inhibition of PDGF-induced c
ell proliferation occurs via a Ras-independent pathway, (C) 2000 Federation
of European Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.